Is alpha-(3-((2-(3,4-Dimethoxyphenyl)ethyl)-methylamino)propyl)-3,4-dimethoxy-alpha-(1-methylethyl)benzeneacetonitrile Safe in Breastfeeding
Question
I am a breastfeeding mother and i want to know if it is safe to use alpha-(3-((2-(3,4-Dimethoxyphenyl)ethyl)-methylamino)propyl)-3,4-dimethoxy-alpha-(1-methylethyl)benzeneacetonitrile? Is alpha-(3-((2-(3,4-Dimethoxyphenyl)ethyl)-methylamino)propyl)-3,4-dimethoxy-alpha-(1-methylethyl)benzeneacetonitrile safe for nursing mother and child? Does alpha-(3-((2-(3,4-Dimethoxyphenyl)ethyl)-methylamino)propyl)-3,4-dimethoxy-alpha-(1-methylethyl)benzeneacetonitrile extracts into breast milk? Does alpha-(3-((2-(3,4-Dimethoxyphenyl)ethyl)-methylamino)propyl)-3,4-dimethoxy-alpha-(1-methylethyl)benzeneacetonitrile has any long term or short term side effects on infants? Can alpha-(3-((2-(3,4-Dimethoxyphenyl)ethyl)-methylamino)propyl)-3,4-dimethoxy-alpha-(1-methylethyl)benzeneacetonitrile influence milk supply or can alpha-(3-((2-(3,4-Dimethoxyphenyl)ethyl)-methylamino)propyl)-3,4-dimethoxy-alpha-(1-methylethyl)benzeneacetonitrile decrease milk supply in lactating mothers?
alpha-(3-((2-(3,4-Dimethoxyphenyl)ethyl)-methylamino)propyl)-3,4-dimethoxy-alpha-(1-methylethyl)benzeneacetonitrile lactation summary
- DrLact safety Score for alpha-(3-((2-(3,4-Dimethoxyphenyl)ethyl)-methylamino)propyl)-3,4-dimethoxy-alpha-(1-methylethyl)benzeneacetonitrile is 1 out of 8 which is considered Safe as per our analyses.
- A safety Score of 1 indicates that usage of alpha-(3-((2-(3,4-Dimethoxyphenyl)ethyl)-methylamino)propyl)-3,4-dimethoxy-alpha-(1-methylethyl)benzeneacetonitrile is mostly safe during lactation for breastfed baby.
- Our study of different scientific research also indicates that alpha-(3-((2-(3,4-Dimethoxyphenyl)ethyl)-methylamino)propyl)-3,4-dimethoxy-alpha-(1-methylethyl)benzeneacetonitrile does not cause any serious side effects in breastfeeding mothers.
- Most of scientific studies and research papers declaring usage of alpha-(3-((2-(3,4-Dimethoxyphenyl)ethyl)-methylamino)propyl)-3,4-dimethoxy-alpha-(1-methylethyl)benzeneacetonitrile safe in breastfeeding are based on normal dosage and may not hold true for higher dosage.
- Score calculated using the DrLact safety Version 1.2 model, this score ranges from 0 to 8 and measures overall safety of drug in lactation. Scores are primarily calculated using publicly available case studies, research papers, other scientific journals and publically available data.
Answer by Dr. Ru: About alpha-(3-((2-(3,4-Dimethoxyphenyl)ethyl)-methylamino)propyl)-3,4-dimethoxy-alpha-(1-methylethyl)benzeneacetonitrile usage in lactation
It is excreted in breast milk in clinically non-significant amount and no problems have been observed in infants whose mothers were receiving this treatment.Plasma levels in these infants were undetectable or very low. alpha-(3-((2-(3,4-Dimethoxyphenyl)ethyl)-methylamino)propyl)-3,4-dimethoxy-alpha-(1-methylethyl)benzeneacetonitrile may induce to an increase of plasma Prolactin levels. American Academy of Pediatrics: usually compatible with breastfeeding medication.WHO List of Essential Medicines 2002: compatible with breastfeeding.
Answer by DrLact: About alpha-(3-((2-(3,4-Dimethoxyphenyl)ethyl)-methylamino)propyl)-3,4-dimethoxy-alpha-(1-methylethyl)benzeneacetonitrile usage in lactation
Limited information indicates that maternal doses of alpha-(3-((2-(3,4-Dimethoxyphenyl)ethyl)-methylamino)propyl)-3,4-dimethoxy-alpha-(1-methylethyl)benzeneacetonitrile up to 360 mg daily produce low levels in milk and newborns may have detectable alpha-(3-((2-(3,4-Dimethoxyphenyl)ethyl)-methylamino)propyl)-3,4-dimethoxy-alpha-(1-methylethyl)benzeneacetonitrile serum levels, but levels are low. alpha-(3-((2-(3,4-Dimethoxyphenyl)ethyl)-methylamino)propyl)-3,4-dimethoxy-alpha-(1-methylethyl)benzeneacetonitrile would not be expected to cause any adverse effects in breastfed infants, especially if the infant is older than 2 months.
alpha-(3-((2-(3,4-Dimethoxyphenyl)ethyl)-methylamino)propyl)-3,4-dimethoxy-alpha-(1-methylethyl)benzeneacetonitrile Side Effects in Breastfeeding
No adverse reactions have been reported among 3 infants aged 13 days, 8 weeks and 3 months who were exposed to alpha-(3-((2-(3,4-Dimethoxyphenyl)ethyl)-methylamino)propyl)-3,4-dimethoxy-alpha-(1-methylethyl)benzeneacetonitrile in breastmilk.[2][3][4]
alpha-(3-((2-(3,4-Dimethoxyphenyl)ethyl)-methylamino)propyl)-3,4-dimethoxy-alpha-(1-methylethyl)benzeneacetonitrile Possible Effects in Breastfeeding
alpha-(3-((2-(3,4-Dimethoxyphenyl)ethyl)-methylamino)propyl)-3,4-dimethoxy-alpha-(1-methylethyl)benzeneacetonitrile can cause hyperprolactinemia and galactorrhea.[5][6] The clinical relevance of these findings in nursing mothers is not known. The maternal prolactin level in a mother with established lactation may not affect her ability to breastfeed.
Alternate Drugs
Lidocaine(Safe)
Timolol(Safe)
Levobunolol(Low Risk)
Disopyramide(Safe)
Labetalol(Safe)
Sotalol(Low Risk)
Diltiazem(Safe)
Amiodarone(Unsafe)
Propranolol(Safe)
Bisoprolol(Low Risk)
Digoxin(Safe)
Quinidine(Safe)
Atenolol(Unsafe)
Propafenone(Low Risk)
Procainamide(Safe)
Acebutolol(Unsafe)
Nadolol(Unsafe)
Flecainide(Safe)
Mexiletine(Safe)
Metoprolol(Safe)
Verapamil(Safe)
Nicardipine(Safe)
Felodipine(Low Risk)
Terazosin(Unsafe)
Methyldopa(Safe)
Bendroflumethiazide(Unsafe)
Verapamil(Safe)
Telmisartan(Unsafe)
Benazepril(Safe)
Nitrendipine(Safe)
Enalapril(Safe)
Prazosin(Unsafe)
Lisinopril(Low Risk)
Levobunolol(Low Risk)
Timolol(Safe)
Trandolapril(Dangerous)
Torsemide(Low Risk)
Losartan(Low Risk)
Labetalol(Safe)
Amlodipine(Low Risk)
Nisoldipine(Low Risk)
Irbesartan(Unsafe)
Isradipine(Low Risk)
Sotalol(Low Risk)
Spironolactone(Safe)
Indapamide(Low Risk)
Carvedilol(Low Risk)
Diltiazem(Safe)
Reserpine(Unsafe)
Nimodipine(Safe)
Propranolol(Safe)
Ramipril(Low Risk)
Eprosartan(Low Risk)
Hydrochlorothiazide(Safe)
Bisoprolol(Low Risk)
Doxazosin(Safe)
Bosentan(Low Risk)
Hydralazine(Safe)
Nifedipine(Safe)
Chlorthalidone(Dangerous)
Guanfacine(Low Risk)
Furosemide(Low Risk)
Atenolol(Unsafe)
Chlorothiazide(Safe)
Fosinopril(Low Risk)
Captopril(Safe)
Acebutolol(Unsafe)
Nebivolol(Unsafe)
Minoxidil(Safe)
Nadolol(Unsafe)
Bumetanide(Low Risk)
Valsartan(Low Risk)
Metoprolol(Safe)
Verapamil(Safe)
Nitrendipine(Safe)
Amlodipine(Low Risk)
Cinnarizine(Low Risk)
Nisoldipine(Low Risk)
Isradipine(Low Risk)
Diltiazem(Safe)
Nimodipine(Safe)
Nifedipine(Safe)
Nicardipine(Safe)
Felodipine(Low Risk)
Amlodipine(Low Risk)
Cinnarizine(Low Risk)
Nisoldipine(Low Risk)
Isradipine(Low Risk)
Diltiazem(Safe)
Nimodipine(Safe)
Nifedipine(Safe)
Hydralazine(Safe)
Sildenafil(Safe)
Nitroglycerin(Safe)
Nebivolol(Unsafe)
Minoxidil(Safe)
Nicardipine(Safe)
Felodipine(Low Risk)
Verapamil(Safe)
Nitrendipine(Safe)